Rational use of moxifloxacin for tuberculosis treatment

Lancet Infect Dis. 2011 Apr;11(4):259-60. doi: 10.1016/S1473-3099(11)70036-6.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Aza Compounds / therapeutic use*
  • Clinical Trials as Topic
  • Fluoroquinolones
  • Humans
  • Moxifloxacin
  • Mycobacterium tuberculosis / drug effects*
  • Quinolines / therapeutic use*
  • Treatment Outcome
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin